Nicotinic Acetylcholine Receptor Partial Antagonist Polyamides from Tunicates and Their Predatory Sea Slugs

Area of Science:

• Marine natural products chemistry
• Neuropharmacology
• Drug discovery

Background:

• Sea slugs and tunicates are sources of novel bioactive compounds.
• Neuroactive compounds are crucial for developing pain therapeutics.
• Acetylcholine signaling plays a key role in nociception and sympathetic functions.

Purpose of the Study:

• To identify and characterize neuroactive components from *Pleurobranchus forskalii* and *Didemnum molle*.
• To elucidate the chemical structures of novel compounds, named molleamines A-E.
• To evaluate the pharmacological activity of molleamine C on acetylcholine-induced calcium flux and specific nicotinic acetylcholine receptors (nAChRs).

Main Methods:

• Spectroscopic analysis for structure elucidation.
• Total synthesis of molleamines A and C.
• Calcium flux assays in peptidergic nociceptors and sympathetic neurons.
• Electrophysiology to determine nAChR subtype specificity and potency (IC50 values).

Main Results:

• Molleamines A-E were identified as major neuroactive components.
• Synthetic molleamine C (3) completely blocked acetylcholine-induced calcium flux in peptidergic nociceptors.
• Compound 3 selectively blocked α3β4 and α6/α3β4 nAChRs, acting as a partial antagonist with no partial agonist activity.
• Molleamine C also partially blocked acetylcholine-induced calcium flux in sympathetic neurons.

Conclusions:

• Molleamine C is a potent and selective antagonist of specific nAChR subtypes involved in pain and sympathetic signaling.
• The unique biological properties of molleamine C make it a promising lead compound for developing novel neuroactive drugs.
• This study highlights the potential of marine organisms as a source for discovering new therapeutic agents.